Evidence map›Paper›PMID 18849193›Full record

Trial reportThe Lancet. Neurology2008

Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial.

Mats Engström, Thomas Berg, Anna Stjernquist-Desatnik, Sara Axelsson, Anne Pitkäranta, Malou Hultcrantz, Mervi Kanerva, Per Hanner, Lars Jonsson

Registry-linked trialAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in The Lancet. Neurology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00510263 (A Multicentre Placebo-Controlled Evaluation of Prednisolone and/or Valaciclovir for the Treatment of Bell's Palsy), which is not on this map. Cited by 121 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 12 pooled it
16.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00510263 phase4completednot on this map

A Multicentre Placebo-Controlled Evaluation of Prednisolone and/or Valaciclovir for the Treatment of Bell's Palsy

TypeinterventionalSponsorUppsala University HospitalRan2001 to 2007Enrolled839ConditionsBell's PalsyArmsPrednisolone + placebo, Valaciclovir + placebo, Prednisolone + valaciclovir, Placebo + placebo
3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 12 syntheses or guidelines pooled it, 486 citations in OpenAlex.

  1. Comparison of oral versus intravenous steroid in the management of Bell's palsy: a systematic review and meta-analysis of randomized clinical trials.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Surgical interventions for the early management of Bell's palsy.The Cochrane database of systematic reviews · 2021
    Pooled it
  6. Antiviral treatment for Bell's palsy (idiopathic facial paralysis).The Cochrane database of systematic reviews · 2019
    Pooled it
  7. Corticosteroids for Bell's palsy (idiopathic facial paralysis).The Cochrane database of systematic reviews · 2016
    Pooled it
  8. Bell's palsy.BMJ clinical evidence · 2014
    Pooled it
  9. Hyperbaric oxygen therapy for Bell's palsy.The Cochrane database of systematic reviews · 2012
    Pooled it
  10. Bell's palsy.BMJ clinical evidence · 2011
    Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Role of Kabat rehabilitation in facial nerve palsy: a randomised study on severe cases of Bell's palsy.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2016
    Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Mats EngströmDepartment of Otorhinolaryngology and Head and Neck Surgery, Uppsala University Hospital, Uppsala, Sweden. mats.engstrom@akademiska.se
Thomas Berg
Anna Stjernquist-Desatnik
Sara Axelsson
Anne Pitkäranta
Malou Hultcrantz
Mervi Kanerva
Per Hanner
Lars Jonsson
Uppsala University Hospital · SEHelsinki University Hospital · FILund University · SEKarolinska University Hospital · SESahlgrenska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious trials of corticosteroid or antiviral treatments for Bell's palsy have been underpowered or have had insufficient follow-up. The aim of this study was to compare the short-term and long-term effects of prednisolone and valaciclovir in the recovery of the affected facial nerve in a large number of patients.

methodsIn this randomised, double-blind, placebo-controlled, multicentre trial, patients aged 18 to 75 years who sought care directly or were referred from emergency departments or general practitioners within 72 h of onset of acute, unilateral, peripheral facial palsy, between May, 2001, and September, 2006, were assessed. Patients were randomly assigned in permuted blocks of eight to receive placebo plus placebo; 60 mg prednisolone per day for 5 days then reduced by 10 mg per day (for a total treatment time of 10 days) plus placebo; 1000 mg valaciclovir three times per day for 7 days plus placebo; or prednisolone (10 days) plus valaciclovir (7 days). Follow-up was for 12 months. The primary outcome event was time to complete recovery of facial function, as assessed with a regional Sunnybrook scale score of 100 points. Analysis was by modified intention to treat. This study is registered with ClinicalTrials.gov, number NCT00510263.

findingsOf 839 patients who were randomly assigned, 829 were included in the modified intention-to-treat analysis: 206 received placebo plus placebo, 210 prednisolone plus placebo, 207 valaciclovir plus placebo, and 206 prednisolone plus valaciclovir. Time to recovery was significantly shorter in the 416 patients who received prednisolone compared with the 413 patients who did not (hazard ratio 1.40, 95% CI 1.18 to 1.64; p<0.0001). There was no difference in time to recovery between the 413 patients treated with valaciclovir and the 416 patients who did not receive valaciclovir (1.01, 0.85 to 1.19; p=0.90). The number of patients with adverse events was similar in all treatment arms.

interpretationPrednisolone shortened the time to complete recovery in patients with Bell's palsy, whereas valaciclovir did not affect facial recovery.

Indexed as

AcyclovirAdolescentAdultAgedAnti-Inflammatory AgentsAntiviral AgentsBell PalsyDouble-Blind MethodDrug Administration ScheduleDrug Therapy, CombinationFemaleHerpes SimplexHumansMaleMiddle AgedPlacebosAcyclovirAnti-Inflammatory AgentsAntiviral AgentsPlacebosPrednisoloneValacyclovirValine

Identifiers

PMID18849193
OpenAlexW2156798246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.